A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
Status:
Completed
Trial end date:
2016-07-21
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to assess the irritation and sensitisation potential
of HAT1 topical products after repeated patch applications to healthy human participants by
following conventional Repeated Insult (HRIPT), Cumulative Irritation (CIT), and
Phototoxicity (PT) methodologies under the supervision of dermatologists.